investor lawsuit

Rosen Law Firm files securities class action against $GPK, alleging false statements on financial performance and operations. Investors may pursue compensation.

Rosen Law Firm encourages $UPST investors to join class action lawsuit over alleged false statements about Model 22 AI tool. Lead plaintiff deadline June 8, 2026.

Rosen Law Firm files securities class action against Boston Scientific, alleging false statements about U.S. Electrophysiology segment sustainability. Investors have until May 4 deadline to join.

monday.com faces securities class action over alleged false growth statements. Investors have until May 11, 2026 to claim lead plaintiff status.

Rosen Law Firm recruits Medpace investors for class action alleging false backlog statements. Lead plaintiff deadline: June 8, 2026.

Rosen Law Firm seeks lead plaintiffs in securities class action against Aldeyra Therapeutics over alleged reproxalap trial misstatements. Deadline: May 29, 2026.

Soleno Therapeutics faces securities litigation alleging undisclosed DCCR safety risks during March-November 2025. Lead plaintiff deadline: May 5, 2026.

Rosen Law Firm filed securities class action against Trip.com over alleged false statements on regulatory risks. Investors have until May 11, 2026 to become lead plaintiffs.

Rosen Law Firm notifies $IT investors of ongoing securities class action against Gartner alleging false statements about growth rates and contract targets. Lead plaintiff deadline approaching.

Rosen Law Firm urges $MNDY investors to join securities class action alleging false revenue growth statements. Deadline approaching for lead plaintiff and class member claims.

Rosen Law Firm files securities class action against Medpace Holdings for alleged false statements regarding business metrics and financial performance, urging investors to act before deadline.

Rosen Law Firm urges Aquestive Therapeutics investors to secure legal counsel before deadlines in securities class action alleging false product and disclosure statements.

Rosen Law Firm sues Aldeyra Therapeutics for false reproxalap trial claims. Lead plaintiff deadline: May 29, 2026.

Vita Coco faces securities law investigation over alleged investor deception regarding Costco risk and operations. Stock fell 11% after March 26 NINGI Research report.

Rosen Law Firm urges Apollo Global ($APO) investors to join securities lawsuit alleging executives falsely denied business dealings with Epstein. Lead plaintiff deadline: May 1, 2026.

Rosen Law Firm urges $PSFE investors with $100k+ losses to join class action alleging false statements about ecommerce exposure and merchant risks.

Rosen Law Firm files securities class action against Snowflake alleging executives concealed material information about product efficiency and pricing changes affecting consumption and revenues.

Rosen Law Firm files securities class action against $ALDX over alleged misleading statements regarding reproxalap clinical trial results. Lead plaintiff deadline set for May 29, 2026.

Rosen Law Firm files securities class action against Trip.com Group ($TCOM), alleging false statements on business operations and regulatory risks. Investors urged to secure counsel before deadlines.

Rosen Law Firm urges Snowflake investors to join securities class action alleging the company made misleading statements while concealing material negative information, causing stock price losses.